bmi md semaglutide EllieMD How Do You Qualify for

International orders: Email [email protected] for a custom quote Description DESCRIPTION SLU-PP-332 100mcg x 100 Capsules is a synthetic small-molecule investigational compound characterized as a pan-agonist of the estrogen-related receptor (ERR) family, with reported binding affinity toward the ERR isoform

Your healthcare provider will provide you with the kit for the procedure, as well as precise instructions on how to perform it

Larger studies at therapeutic doses are needed to confirm reproductive and metabolic effects

A warning about compounded semaglutide: the FDA does not approve compounded versions of GLP-1s, and the agency has issued specific warnings about safety risks in 2026

Any decision to reduce or stop medication should be made with a healthcare provider

Although both GLP-1 and GIP stimulate insulin secretion, GLP-1 also reduces appetite while GIP has direct actions on fat cells